{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": "International Business", "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Japanese drug company Astellas Pharma will acquire Ocata, biotechnology firm known for its work developing human embryonic stem cells, for around $379 million.", "type_of_material": "News", "word_count": "375", "lead_paragraph": "The sometimes controversial pioneer in developing human embryonic stem cells will be acquired by one of the major drug companies in Japan.", "pub_date": "2015-11-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Astellas Pharma to Acquire Ocata Therapeutics", "print_headline": "Drug Maker in a Deal for Pioneer in Stem Cells"}, "snippet": "The sometimes controversial pioneer in developing human embryonic stem cells will be acquired by one of the major drug companies in Japan.", "multimedia": [{"height": 126, "url": "images/2015/11/11/business/stem-web1/stem-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/11/business/stem-web1/stem-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 902, "url": "images/2015/11/11/business/stem-web1/stem-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "902", "xlarge": "images/2015/11/11/business/stem-web1/stem-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/11/business/stem-web1/stem-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/11/business/stem-web1/stem-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/11/business/international/astellas-pharma-ocata-therapeutics-acquisition.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Astellas Pharma", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Ocata Therapeutics Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Stem Cells (Embryonic)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "56418baf38f0d80e74ff984d", "source": "The New York Times"}